chr12-109401121-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001101421.4(MYO1H):c.599G>T(p.Ser200Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00354 in 1,613,944 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 17 hom. )
Consequence
MYO1H
NM_001101421.4 missense
NM_001101421.4 missense
Scores
4
9
4
Clinical Significance
Conservation
PhyloP100: 5.49
Genes affected
MYO1H (HGNC:13879): (myosin IH) Predicted to enable actin filament binding activity and microfilament motor activity. Predicted to be involved in actin filament organization and vesicle transport along actin filament. Predicted to be part of myosin complex. Predicted to be active in several cellular components, including actin cytoskeleton; microvillus; and vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.017060041).
BP6
Variant 12-109401121-G-T is Benign according to our data. Variant chr12-109401121-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 717107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 17 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO1H | NM_001101421.4 | c.599G>T | p.Ser200Ile | missense_variant | 6/32 | ENST00000310903.10 | |
MYO1H | XM_011538223.3 | c.551G>T | p.Ser184Ile | missense_variant | 7/34 | ||
MYO1H | XM_047428738.1 | c.551G>T | p.Ser184Ile | missense_variant | 5/31 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO1H | ENST00000310903.10 | c.599G>T | p.Ser200Ile | missense_variant | 6/32 | 5 | NM_001101421.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00207 AC: 315AN: 152178Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
315
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00216 AC: 537AN: 249032Hom.: 3 AF XY: 0.00216 AC XY: 292AN XY: 135082
GnomAD3 exomes
AF:
AC:
537
AN:
249032
Hom.:
AF XY:
AC XY:
292
AN XY:
135082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00369 AC: 5398AN: 1461648Hom.: 17 Cov.: 30 AF XY: 0.00353 AC XY: 2570AN XY: 727106
GnomAD4 exome
AF:
AC:
5398
AN:
1461648
Hom.:
Cov.:
30
AF XY:
AC XY:
2570
AN XY:
727106
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00207 AC: 315AN: 152296Hom.: 1 Cov.: 32 AF XY: 0.00187 AC XY: 139AN XY: 74472
GnomAD4 genome
AF:
AC:
315
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
139
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
31
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
30
ExAC
AF:
AC:
255
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | MYO1H: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D
REVEL
Pathogenic
Sift
Pathogenic
.;D
Sift4G
Pathogenic
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at